Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
7,727,518
-
Share change
-
+3,668,527
-
Total reported value
-
$240,322,086
-
Price per share
-
$31.10
-
Number of holders
-
80
-
Value change
-
+$114,069,942
-
Number of buys
-
56
-
Number of sells
-
7
Institutional Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q3 2017
As of 30 Sep 2017,
REATA PHARMACEUTICALS INC - CL A (RETA) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,727,518 shares.
The largest 10 holders included
BlackRock Inc., FMR LLC, Novo Holdings A/S, EMERALD ADVISERS INC/PA, VANGUARD GROUP INC, EMERALD MUTUAL FUND ADVISERS TRUST, Cormorant Asset Management, LLC, FRANKLIN RESOURCES INC, PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE, and JPMORGAN CHASE & CO.
This page lists
80
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.